DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded by StockNews.com to Buy Rating

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday.

Other equities analysts have also issued reports about the company. Morgan Stanley cut their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Barrington Research dropped their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Mizuho began coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target on the stock. Evercore ISI reissued an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, UBS Group dropped their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research report on Tuesday, December 3rd. Nine research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $26.33.

DENTSPLY SIRONA Stock Down 2.3 %

Shares of XRAY traded down $0.45 during trading on Friday, reaching $18.76. The company’s stock had a trading volume of 1,454,966 shares, compared to its average volume of 2,340,175. The company has a fifty day moving average of $19.13 and a two-hundred day moving average of $22.29. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $34.91. The company has a market cap of $3.73 billion, a price-to-earnings ratio of -9.06, a P/E/G ratio of 1.88 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the company posted $0.49 EPS. DENTSPLY SIRONA’s quarterly revenue was up .4% on a year-over-year basis. On average, sell-side analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of XRAY. Pacer Advisors Inc. grew its stake in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. Cooke & Bieler LP grew its stake in shares of DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after purchasing an additional 1,794,391 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Invenomic Capital Management LP bought a new position in shares of DENTSPLY SIRONA in the third quarter worth $23,724,000. Finally, National Bank of Canada FI grew its stake in shares of DENTSPLY SIRONA by 85.8% in the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock worth $44,059,000 after purchasing an additional 751,800 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.